BioSpace News Archive

Drug Development

Kevzara® (sarilumab) Data at the 2018 ACR/ARHP Annual Meeting Provide Additional Insight on Safety and Efficacy in Rheumatoid Arthritis

Among 13 Alliance presentations, a late-breaker poster will highlight potential for IL-6 levels to serve as a biomarker to help predict treatment response

October 19, 2018
·
17 min read
Drug Development

ArQule Presents Orphan Disease Clinical Data at the American Society of Human Genetics (ASHG) 2018 Annual Meeting for Its pan-AKT Inhibitor, Miransertib (ARQ 092)

Three poster presentations confirm miransertib’s potential for treating patients with Proteus syndrome and PROS (PIK3CA-Related Overgrowth Spectrum)

October 19, 2018
·
9 min read
Business

Orthofix Schedules Third Quarter 2018 Earnings Release and Conference Call for October 29, 2018

Orthofix Medical Inc. today announced that it plans to release financial results for the third quarter 2018 after market close on Monday, October 29, 2018.

October 19, 2018
·
1 min read
Pharm Country

The Center For Discovery Spotlights Brain Health In The Age Of Complexity; Convenes 3rd Annual Research Conference In New York City

A Focus on Understanding Brain Health from Autism to Alzheimer’s

October 19, 2018
·
3 min read
FDA

Amneal Announces Approval of Carmustine for Injection USP, 100 mg/vial - Preparing for Launch

Amneal Pharmaceuticals, Inc. today announced that it has received FDA approval for a generic version of BiCNU® (carmustine) for injection, 100 mg. The Company is planning to commercialize its Carmustine for Injection in November 2018.

October 19, 2018
·
7 min read
Business

NuVasive Names J. Christopher Barry To Succeed Gregory T. Lucier As Chief Executive Officer; Lucier To Remain Chairman Of The Board

NuVasive, Inc. today announced its Board of Directors has named J. Christopher Barry to succeed Gregory T. Lucier as chief executive officer (CEO) effective November 5, 2018.

October 19, 2018
·
5 min read
Business

RelayHealth Pharmacy Solutions Strengthens Retail Pharmacies’ Efforts to Expand Clinical Services with Medical Billing Platform in Collaboration with STRAND Clinical Technologies

RelayHealth Pharmacy Solutions today announced the development of a new pharmacy platform, RelayRx Medical Billing

October 19, 2018
·
4 min read
Business

Almirall LLC Launches New Name at Fall Clinical Dermatology Congress

Aqua Pharmaceuticals Assumes Parent Company name and becomes Almirall LLC

October 19, 2018
·
3 min read
Drug Development

Sensei Biotherapeutics Reports Results from Phase 1 Clinical Trial of SNS-301, a First-in-Class Cancer Immunotherapy Targeting ASPH, a Novel Tumor-Specific Antigen

SNS-301 demonstrated a favorable safety profile, improvements in disease parameters, and robust antigen-specific immune responses

October 19, 2018
·
6 min read
Genetown

X4 Pharmaceuticals Presents Clinical Data Showing Combination of X4P-001 and Opdivo® (nivolumab) Improved Clinical Responses in RCC Patients Unresponsive to Opdivo Monotherapy

Findings with combination therapy of anti-PD-1 and CXCR4 antagonist in patients with clear cell renal cell carcinoma (ccRCC) presented in Poster Discussion session at ESMO 2018

October 19, 2018
·
4 min read